[Treatment of ischemic heart disease with "coronary drugs" (author's transl)].
The standard treatment of ischemic heart disease consists in the administration of nitrates and beta-sympathicolytic agents. Calcium antagonists are likewise promising. They should be used particularly if beta-sympathicolytic agents are contraindicated. In the beginning special caution should be exercised on combining a beta-sympathicolytic agent with a calcium antagonist. This is best done under clinical supervision since sudden cardiac decompensation, extreme bradycardia and/or disturbed atrioventricular conduction is to be expected. Today the administration of "coronary dilators" is no longer a part of the standard treatment but can at best be regarded as supplementary therapy.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D002118:Calcium / Q000037:antagonists & inhibitors; D002301:Cardiac Glycosides / Q000627:therapeutic use; D003327:Coronary Disease / Q000188:drug therapy* / Q000503:physiopathology; D004341:Drug Evaluation; D006801:Humans; D009566:Nitrates / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D002301:Cardiac Glycosides; D009566:Nitrates; D014665:Vasodilator Agents; D002118:Calcium
Zur Therapie der ischämischen Herzkrankheit mit "Koronartherapeutika"